Positron emission tomography scanning and pathologic assessment of neoadjurvant chemoradiotherapy for esophageal cancer

被引:0
|
作者
Schomas, D. A. [1 ]
Peller, P. J. [1 ]
Donahue, J. M. [1 ]
Nichols, F. C. [1 ]
Lowe, V. [1 ]
Quevedo, J. F. [1 ]
Miller, R. C. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
关键词
D O I
10.1016/j.ijrobp.2008.06.647
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S251 / S252
页数:2
相关论文
共 50 条
  • [21] Positron emission tomography scanning for the diagnosis and management of lung cancer
    Line B.R.
    White C.S.
    [J]. Current Treatment Options in Oncology, 2004, 5 (1) : 63 - 73
  • [22] Positron Emission Tomography/Computed Tomography Alert Finding in an Esophageal Cancer Patient
    Panagiotidis, Emmanouil
    Paschali, Anna
    Chatzipavlidou, Vassiliki
    [J]. INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (01): : 80 - 81
  • [23] The Role of Qualitative Analysis of F18-FDG Positron Emission Tomography in Predicting Pathologic Response following Chemoradiotherapy in Patients with Esophageal Carcinoma
    Klayton, T. L.
    Li, T.
    Yu, J. Q.
    Cheng, J. D.
    Cohen, S. J.
    Meropol, N. J.
    Scott, W. J.
    Xu-Welliver, M.
    Konski, A. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S271 - S272
  • [24] Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer
    Larson, SM
    Schoder, H
    Yeung, H
    [J]. CANCER JOURNAL, 2004, 10 (04): : 243 - 250
  • [25] Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma
    Kukar, Moshim
    Alnaji, Raed M.
    Jabi, Feraas
    Platz, Timothy A.
    Attwood, Kristopher
    Nava, Hector
    Ben-David, Kfir
    Mattson, David
    Salerno, Kilian
    Malhotra, Usha
    Kanehira, Kazunori
    Gannon, James
    Hochwald, Steven N.
    [J]. JAMA SURGERY, 2015, 150 (06) : 555 - 562
  • [26] Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer
    van Heijl, Mark
    Omloo, Jikke M.
    Henegouwen, Mark I. van Berge
    Hoekstra, Otto S.
    Boellaard, Ronald
    Bossuyt, Patrick M.
    Busch, Olivier R.
    Tilanus, Hugo W.
    Hulshof, Maarten C.
    van der Gaast, Ate
    Nieuwenhuijzen, Grard A.
    Bonenkamp, Han J.
    Plukker, John Th.
    Cuesta, Miguel A.
    ten Kate, Fiebo J.
    Pruim, Jan
    van Dekken, Herman
    Bergman, Jacques J.
    Sloof, Gerrit W.
    van Lanschot, J. Jan
    [J]. ANNALS OF SURGERY, 2011, 253 (01) : 56 - 63
  • [27] Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer
    Mac Manus, MP
    Hicks, RJ
    Matthews, JP
    McKenzie, A
    Rischin, D
    Salminen, EK
    Ball, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1285 - 1292
  • [28] Serial positron emission tomography (PET) to assess the response of preoperative induction chemoradiotherapy in advanced esophageal cancer in relation to survival
    Cambier, JP
    Flamen, P
    Van Cutsem, E
    Lerut, A
    Maes, A
    Bormans, G
    Haustermans, K
    Ectors, N
    Mortelmans, L
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 961 - 961
  • [29] Positron emission tomography scanning and gastroenterology
    Urbain, Jean-Luc
    Adams, Paul C.
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2008, 22 (01): : 15 - 16
  • [30] Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma
    Kato, H
    Kuwano, H
    Nakajima, M
    Miyazaki, T
    Yoshikawa, M
    Ojima, H
    Tsukada, K
    Oriuchi, N
    Inoue, T
    Endo, K
    [J]. CANCER, 2002, 94 (04) : 921 - 928